Voya Financial, Inc.·4

May 26, 4:48 PM ET

DeRose Kathleen 4

4 · Voya Financial, Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Voya Director Kathleen DeRose Receives RSU Award

What Happened
Kathleen DeRose, a director of Voya Financial, received a grant of 2,062 restricted stock units (RSUs) on May 21, 2026. The award is reported at a grant value of $169,950 based on a per-share reference price of $82.42. This was an award (derivative grant), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-05-21; Form 4 filed 2026-05-26 (appears later than the usual two-business-day Form 4 filing requirement).
  • Grant: 2,062 restricted stock units; reference price $82.42; total reported value $169,950.
  • Shares/units after the transaction: Not specified in this filing.
  • Footnotes: Each stock unit is a conditional right to receive one share of common stock (RSU). 100% of the RSUs vest at 11:59 pm ET on the date of Voya’s 2027 Annual Meeting of Shareholders.
  • Transaction type: Award/Grant (code A) — compensation-related equity grant.

Context
RSU grants to directors are common compensation and do not represent an open-market purchase or sale. As a derivative award, these units convert to actual shares only upon vesting (here, at the 2027 annual meeting). Because this is a company grant, it should be viewed as compensation rather than a direct signal of the insider’s current market view. The later-than-expected filing date is noted; timely Form 4 reporting is required under SEC rules and delays can reduce the immediacy of disclosure.

Insider Transaction Report

Form 4
Period: 2026-05-21
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-05-21$82.42/sh+2,062$169,95016,782 total
    Common Stock (2,062 underlying)
Footnotes (2)
  • [F1]Each stock unit represents a conditional right to receive one share of the company's common stock.
  • [F2]100% of the restricted stock units will vest at 11:59pm Eastern Time on the date of the Company's 2027 Annual Meeting of Shareholders.
Signature
/s/ Julie Watson, Attorney-in-Fact|2026-05-26

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT